Cargando…
Pulmonary vasodilation in acute pulmonary embolism – a systematic review
Acute pulmonary embolism is the third most common cause of cardiovascular death. Pulmonary embolism increases right ventricular afterload, which causes right ventricular failure, circulatory collapse and death. Most treatments focus on removal of the mechanical obstruction caused by the embolism, bu...
Autores principales: | Lyhne, Mads Dam, Kline, Jeffrey Allen, Nielsen-Kudsk, Jens Erik, Andersen, Asger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057411/ https://www.ncbi.nlm.nih.gov/pubmed/32180938 http://dx.doi.org/10.1177/2045894019899775 |
Ejemplares similares
-
Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021) -
Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial
por: Andersen, Asger, et al.
Publicado: (2021) -
A porcine in-vivo model of acute pulmonary embolism
por: Schultz, Jacob, et al.
Publicado: (2017) -
Levosimendan in pulmonary hypertension and right heart
failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018) -
Putative Biomarkers for Acute Pulmonary Embolism in Exhaled Breath Condensate
por: Gade, Inger Lise, et al.
Publicado: (2021)